MSLN and neoplasm: Additional data come from studies on PDAC, which show that NF-κB, activated by MSLN, can also act as a transcriptional activator of MSLN itself, establishing a positive feedback loop that promotes tumor progression by conferring resistance to tumor necrosis factor alpha (TNF-α)–induced apoptosis [30].